Infectious: Page 2

New assay developed for persistent African HIV strains

By LabPulse.com staff writers

A multinational research team has developed a test to measure the persistence of HIV in people who have been infected by strains of the virus found predominantly in Africa, providing a necessary tool in the search for a cure for HIV.

July 9, 2024

BARDA awards Moderna $176M for pandemic flu vaccine development

By LabPulse.com staff writers

The Biomedical Advanced Research and Development Authority (BARDA) has awarded Moderna approximately $176 million for the development of an mRNA-based pandemic influenza vaccine.

July 2, 2024

Day Zero shares AI-based approach to antimicrobial susceptibility testing

By LabPulse.com staff writers

A Day Zero Diagnostics research team has unveiled a new approach to antimicrobial susceptibility testing using artificial intelligence (AI) to guide analysis.

June 14, 2024

Sysmex POC urine test wins $10.2M prize

By LabPulse.com staff writers

Product offers potential to end the "just in case" prescribing that is currently prevalent and which promotes the development of antibiotic resistance.

June 13, 2024

FDA grants 510(k) clearance to Genetic Signature for parasitic GI infection kit

By LabPulse.com staff writers

The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Genetic Signature's EasyScreen Gastrointestinal Parasite Detection Kit and GS1 automated molecular workflow.

June 7, 2024

POC test offers low-cost way to screen for toxoplasmosis during pregnancy

By Liz Carey

Gestational screening programs might benefit from a new clinical laboratory point-of-care (POC) diagnostic test that hunts for a parasite that can be transmitted during pregnancy.

May 29, 2024

GMU researchers receive $1.2M in funding for Lyme disease urine test

By LabPulse.com staff writers

Researchers at George Mason University (GMU) have received $1.2 million in federal funding from the U.S. Department of the Army to develop a urine-based test for the detection and diagnosis of Lyme disease.

May 24, 2024

University of Florida researchers develop CRISPR-based assay for HPV detection

By LabPulse.com staff writers

Researchers at the University of Florida have developed a testing method that utilizes CRISPR gene-editing technology to detect HPV in blood or saliva samples that could promote earlier cervical cancer detection.

May 7, 2024

Scout secures CARB-X grant to advance diagnostic test development

By LabPulse.com staff writers

Scout, formerly Uh Oh Labs, will advance its point-of-care (POC) diagnostic test for sexually transmitted infections (STIs) with a new $1 million accelerator grant.

April 22, 2024

Researchers tweak TB treatment assay to support global use

By Nick Paul Taylor

Researchers have developed a tuberculosis (TB) treatment assay that could be a faster, simpler method for monitoring patients.

April 10, 2024

Researchers map protein biomarkers in sepsis fight

By Liz Carey

Swedish researchers are mapping patterns of protein biomarkers in sepsis that could be useful for simple blood tests in the emergency department, according to research to be presented at ECCMID 2024.

April 2, 2024

WHO launches new guidance on TB diagnostics

By LabPulse.com staff writers

The World Health Organization has published updated guidance for the diagnosis of tuberculosis (TB), including new recommendations on the use of next-generation sequencing for the diagnosis of drug-resistant TB.

March 21, 2024

Previous Page

Page 2 of 152

Next Page